Amsterdam’s Fortaegis raised a $50 million Series A led by Serendipity Capital, with Tokyo Electron’s venture arm in. Valuation was not disclosed. Commercial manufacturing is aimed at 2027. Quantum-safe and 200× speed claims are company/FT-attributed, not independent benchmarks.
Fresh Sep 13–14 tape: Tandem Health $100M Series B (EQT Scaleup’s first healthcare check), Qupital $300M Series C + ABS package, Synapse Analytics $13M Partech Series A — plus what we skipped (NeoCognition April reprint, Mecka talks).
Abu Dhabi–based Synapse Analytics raised $13M Series A led by Partech on September 14, 2026 ($17M lifetime) for on-prem agentic credit decisioning across MENA, Africa, and LatAm. Valuation not disclosed — and it is not the bankrupt Synapse BaaS firm.
Hong Kong’s Qupital announced $300M in combined Series C and ABS commitments on September 13–14, 2026, led by M Capital with MUFG and Quester — after claiming $9.5B+ cumulative loans. Equity vs ABS split and valuation were not disclosed.
Tandem Health closed a $100M Series B led by EQT’s Scaleup Europe Fund on September 14, 2026 — the fund’s first healthcare check — at 10,000 care organisations across 14 markets and $160M total funding. Valuation was not disclosed.
Gap-fill for Sep 9–12, 2026 beyond the mega-round PRs: Perry Weather $110M Series C, Wint $36M Series D, Aqua $15M Series A, FAZE $6M seed, and IVEX €5M Series A — with deep dives linked.
